Potential therapeutic targets associated with abnormal adipose tissue function have been identified; these targets include the NLRP3 inflammasome, SIRT, and important lipid-related genes linked to IPF. The gene discussed is NLRP3; the disease is idiopathic pulmonary fibrosis.